This interactive panel discussion will feature current market information and the observations of three D&O insurance industry professionals: Jacqueline Urban, Senior Vice President, Legal & Claims Practice at Aon Risk Solutions; Maria Fazzolari, Senior Manager of the Directors and Officers Claims Group at Freedom Specialty, a Nationwide Company; and Ethan D. Lenz, Insurance Partner at Foley. The session will be moderated by Foley Partner John R. Landis, and will address the following:
- A D&O market overview, including trends in pricing, capacity, and claims
- A summary of D&O litigation
- Developments in coverage terms
The panel discussion will be a valuable checkpoint for companies, officers, and directors as they consider the best possible coverage (including closing coverage gaps) and the best possible policy terms.
People
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.